- Home
- TXMD vs FTFT Comparison
TXMD vs FTFT Comparison
Compare TXMD & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- FTFT
- Stock Information
- Founded
- TXMD 2008
- FTFT N/A
- Country
- TXMD United States
- FTFT United States
- Employees
- TXMD N/A
- FTFT N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- TXMD Health Care
- FTFT Consumer Discretionary
- Exchange
- TXMD Nasdaq
- FTFT Nasdaq
- Market Cap
- TXMD 12.3M
- FTFT 11.0M
- IPO Year
- TXMD N/A
- FTFT N/A
- Fundamental
- Price
- TXMD $1.19
- FTFT $1.82
- Analyst Decision
- TXMD
- FTFT
- Analyst Count
- TXMD 0
- FTFT 0
- Target Price
- TXMD N/A
- FTFT N/A
- AVG Volume (30 Days)
- TXMD 511.6K
- FTFT 79.6K
- Earning Date
- TXMD 11-12-2025
- FTFT 11-18-2025
- Dividend Yield
- TXMD N/A
- FTFT N/A
- EPS Growth
- TXMD N/A
- FTFT N/A
- EPS
- TXMD N/A
- FTFT N/A
- Revenue
- TXMD $2,559,000.00
- FTFT $2,368,206.00
- Revenue This Year
- TXMD $427.09
- FTFT N/A
- Revenue Next Year
- TXMD N/A
- FTFT N/A
- P/E Ratio
- TXMD N/A
- FTFT N/A
- Revenue Growth
- TXMD 156.93
- FTFT N/A
- 52 Week Low
- TXMD $0.70
- FTFT $1.01
- 52 Week High
- TXMD $2.44
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- TXMD 53.55
- FTFT 37.69
- Support Level
- TXMD $1.19
- FTFT $1.99
- Resistance Level
- TXMD $1.28
- FTFT $2.22
- Average True Range (ATR)
- TXMD 0.13
- FTFT 0.15
- MACD
- TXMD 0.01
- FTFT -0.02
- Stochastic Oscillator
- TXMD 23.88
- FTFT 11.33
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.